DEF: NexGel Seeks Stockholder Approval for Incentive Plan Amendment, Outlines Executive Compensation and Governance

NexGel's proxy statement details proposals for the annual stockholder meeting, including an amendment to the long-term incentive plan and director elections.

Summary

• NexGel, Inc. is holding its Annual Meeting of Stockholders on June 17, 2025, at its corporate headquarters.
• Stockholders will vote on several proposals, including the election of five directors, an amendment to the 2019 Long-Term Incentive Plan, executive compensation, and the ratification of the independent accounting firm.
• The Board of Directors recommends voting FOR the election of directors, FOR the incentive plan amendment, FOR the advisory vote on executive compensation, FOR an advisory vote on executive compensation every three years, and FOR the ratification of the accounting firm.
• The Fourth Amendment to the NexGel, Inc. 2019 Long-Term Incentive Plan seeks to increase the total number of shares of common stock authorized for issuance under such plan by 780,000, to a total of 1,651,429 shares.
• The company is using the SEC's Notice and Access model for delivering proxy materials.
• The record date for determining stockholders eligible to vote is April 22, 2025.
• As of April 30, 2025, there were 7,654,037 shares of common stock outstanding.
• The company has adopted a Code of Business Conduct and Ethics, an insider trading policy, and a policy for the recovery of erroneously awarded compensation.
• The Board has determined that Steven Glassman, Scott R. Henry, Nachum Stein and Dr. Jerome B. Zeldis are independent directors.
• The company's audit committee consists of Mr. Glassman, Mr. Henry and Mr. Stein.
• The company's compensation committee consists of Mr. Glassman, Mr. Henry and Mr. Stein.
• The company's nominating and corporate governance committee consists of Mr. Glassman, Mr. Henry and Mr. Zeldis.
• The company's non-employee directors were each compensated $67,875 in 2024.
• The company's CEO, Adam Levy, received total compensation of $437,550 in 2024.
• The company's former CFO, Adam E. Drapczuk III, received total compensation of $248,229 in 2024.
• The company entered into a 2025 Executive Employment Agreement with Adam Levy, providing for a base salary of $375,000 per year and potential bonuses.
• The company entered into a 2025 Executive Employment Agreement with Joseph F. McGuire to become our Chief Financial Officer to replace Adam E. Drapczuk III, who currently continues to serve as financial consultant to the Company.
• Turner, Stone & Company, L.L.P. has served as the company's independent registered public accounting firm since 2019.
• Audit fees billed by Turner, Stone & Company, L.L.P. were $165,173 for 2024 and $87,010 for 2023.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. The Board's recommendations are positive, but the overall sentiment is driven by the factual nature of the information presented.

Positives

• The company has a comprehensive corporate governance plan in place.
• The company has adopted a Code of Business Conduct and Ethics, an insider trading policy, and a policy for the recovery of erroneously awarded compensation.
• The company is seeking stockholder approval for an amendment to the long-term incentive plan, which is intended to attract and retain key personnel.
• The company has an audit committee, a compensation committee, and a nominating and corporate governance committee, all of which are comprised of independent directors.

Negatives

• The company currently has no females or underrepresented minorities on its Board.
• The company's former CFO, Adam E. Drapczuk III, is no longer an executive officer of the company.

Risks

• The company's success depends on its ability to attract and retain key personnel.
• The company's executive compensation program may not be effective in aligning management's interests with those of stockholders.
• The company's internal controls over financial reporting may not be effective.
• The company may be subject to litigation or regulatory proceedings.

Future Outlook

The company expects to hold future advisory votes on executive compensation every three years, with the next vote expected in 2028.

Management Comments

• On behalf of the Board of Directors, I urge you to submit your vote as soon as possible, even if you currently plan to attend the meeting in person.
• Thank you for your support of our company.
• I look forward to seeing you at the Annual Meeting.

Industry Context

This announcement is typical for publicly traded companies as they prepare for their annual stockholder meetings. The proposals and disclosures are in line with regulatory requirements and standard corporate governance practices.

Comparison to Industry Standards

• The executive compensation structure, including base salary, bonus, and equity incentives, is a common practice among publicly traded companies, particularly in the pharmaceutical and biotechnology sectors.
• The use of performance-based metrics, such as EBITDA and stock price targets, to determine executive bonuses is also a standard industry practice.
• The composition of the Board of Directors, with a majority of independent directors, is consistent with NASDAQ listing requirements and corporate governance best practices.
• The company's audit and compensation committee charters are in line with industry standards and regulatory requirements.
• The fees paid to the independent registered public accounting firm are comparable to those paid by other companies of similar size and complexity.

Management Changes

Corporate Governance

Related Party Transactions

• Certain members of the board of directors and executive team purchased units in the February, August, and November Offerings.

Stakeholder Impact

• Shareholders are asked to vote on key proposals that will impact the company's governance and executive compensation.
• Employees may be affected by changes to the long-term incentive plan.
• The company's financial performance and governance practices can impact its relationships with customers, suppliers, and creditors.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
• The company will hold its Annual Meeting of Stockholders on June 17, 2025.
• The company will file a report on Form 8-K with the SEC to disclose the voting results within four business days after the Annual Meeting.

Key Dates

Keywords

proxy statement, annual meeting, stockholders, executive compensation, corporate governance, incentive plan, directors, audit committee, compensation committee, accounting firm, NexGel